drugset / Trial / NCT02054468

Rocuronium Dose Finding Study After Single-shot or Steady-state Propofol Anesthesia

NCT02054468

Completed 82 enrolled Technical University of Munich
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to determine the effective-doses ED-50 and ED-95 (the doses required for a 50% and 95% twitch inhibition, respectively) of the non-depolarizing muscle relaxant rocuronium after single-shot or steady-state propofol anesthesia in a clinical setting.

Timeline

Start
2012-03
Primary completion
2014-02
Completion
2014-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 1.5 mg/kg Intravenous
Comparator Propofol Small molecule 2.5 mg/kg Intravenous
Comparator Propofol Small molecule 4 mg/kg Intravenous
Comparator Propofol Small molecule 6 mg/kg Intravenous
Subject Rocuronium Other / unclassified 0.07 mg/kg
Subject Rocuronium Other / unclassified 0.1 mg/kg
Subject Rocuronium Other / unclassified 0.15 mg/kg
Subject Rocuronium Other / unclassified 0.2 mg/kg
Subject Rocuronium Other / unclassified 0.3 mg/kg
Subject Rocuronium Other / unclassified 0.45 mg/kg
Background Remifentanil Small molecule 0.1 ug/kg
Background Remifentanil Small molecule 0.2 ug/kg

Indications

No indication recorded.